Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case.

Presenter
Michael S. Benninger, MD
Professor of Otolaryngology-Head and Neck Surgery
Lerner College of Medicine
The Cleveland Clinic
President, International Association of Phonosurgery
Cleveland, Ohio

Link to full program:
https://bit.ly/4kweynG

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including:

• Documenting obesity as a diagnosis for patients with diabetes when appropriate
• Streamlining processes to ensure patients return for follow-up
• Dedicating a care manager to initiate patient outreach
• Implementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously.

Presenters

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Colten Bracken, MD, FAAFP
Board of Directors for RHAU & UAFP
Owner/Medical Director
Main Street Family Medicine, PLLC
Enterprise, Utah

Link to full program:
https://bit.ly/3IBFZi5

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include:

• Steatotic liver disease and PBC
• Vibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBC
• PPAR agonists and IBATs for PBC treatment

Presenter:

Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH
Associate Professor
NIHR Birmingham BRC
University of Birmingham
Consultant Hepatologist, Liver Unit
University Hospitals Birmingham
Birmingham, United Kingdom

Link to full program:
https://bit.ly/44ySoL3

Follow along with the slides:
https://bit.ly/3IvwQrj

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

.

In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:

• Patient candidacy considerations
• Treatment advancement strategies that go beyond topical therapies
• The importance of patient-centered care that address patients’ fears and needs
• A detailed patient case to highlight take home points

Presenter

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including:

• The available biologic therapies that specifically target IL-13
• Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm
• How these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitors
• A detailed patient case to highlight take home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including:

• The information to collect during patient visits
• The available resources to help you submit prior authorizations
• The supporting documents that are often necessary to accompany prior authorizations
• How to address denials and appeals
• When to access manufacturer-based or foundation-based financial assistance

Presenters
Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Manish Shah, MD
Clinical Associate Faculty MS1 Preceptor
University of Florida College of Medicine
Gainesville, Florida

Martha Grugel, MA
Medical Assistant
Wesley Chapel, Florida

Link to full program:
https://bit.ly/45P0v8z

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

• Contributors to epidermal barrier dysfunction (eg, environmental triggers)
• IL-13 as a key cytokine in AD pathogenesis
• Targeted AD therapies that inhibit IL-13
• A detailed patient case to highlight take-home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Program page:
https://bit.ly/4kTP04D

In this podcast, Anne E. O’Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis bronchiectasis (NCFBE), including:

• Airway clearance as a foundation of NCFBE management
• Strategies to address inflammation and exacerbations
• Emerging therapies in clinical development
• How to individualize treatment to NCFBE phenotypes and endotypes

Presenter
Anne E. O’Donnell, MD
Professor of Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonology Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Medical Center
Washington, DC

Program page:
https://bit.ly/4mZbYsm